ARCHIVES

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

This article is from The Cancer Letter archive.

Vol. 14 No. 25 | June 17, 1988

Download PDF Visit The Full Archive

Related Articles

Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees

January 6, 1984

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

DCE Board Recompetition Concepts

July 17, 1987

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

NCI Plans $175 Million In Program Cuts To Cover Deficit, Fund New Initiatives

November 17, 2006

Ohio State recruits neurosurgeon from Harvard to lead new department.

January 9, 2004